TVAX Biomedical, Inc.
↗Lenexa, Kansas, United States
TVAX Biomedical is a clinical-stage biotechnology company focused on developing novel targeted cell-based immunotherapies for the treatment of cancer. The company's proprietary TVAX Immunotherapy platform combines personalized cancer cell vaccination with activated killer T cell therapy, representing a dual-mechanism approach to cancer immunotherapy. Founded in 2004 and headquartered in Lenexa, Kansas, TVAX has demonstrated the potential to effectively treat numerous aggressive solid cancers with significantly lower manufacturing costs and toxicity profiles compared to other cellular immunotherapies such as CAR-T therapies. The company has established a cGMP manufacturing facility in Columbia, Missouri to support its clinical development programs.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2004
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$14.9M
Investors:eGrowth Ventures, Kansas Bioscience Authority, Mid America Angels, HHS (grants)
PIPELINE
Stage:Phase 2b/3
Lead Drug Stage:Phase 2b/3 registrational trial
Modalities:Adoptive T cell therapy, Cancer vaccine, Neoantigen-specific T cell therapy
Active Trials:5
Trial Phases:Phase 2: 1 | Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Genelux Corporation: Joint venture V2ACT Therapeutics for combination therapy development, ELIAS Animal Health: Technology licensee for veterinary applications; spinoff subsidiary focusing on canine osteosarcoma treatment, Capital Health Cancer Center: Clinical trial site (2024) - one of five US sites for TVI-Brain-1, University of Kansas Cancer Center: Clinical trial site
COMPETITION
Position:Emerging niche player in adoptive T cell immunotherapy
Competitors:Moderna, Jazz Pharmaceuticals, BeiGene, CAR-T therapy developers (general category)
LEADERSHIP
Key Executives:
Wayne O. Carter - Chief Executive Officer & Board Member
Gary W. Wood - Founder, Chairman & Chief Scientific Officer
Tammie A. Wahaus - Chief Financial Officer
Barry S. Skikne - Chief Medical Officer & Board Member
Wesley E. Griffitt - Board Member
Scientific Founders:Gary W. Wood, Ph.D.
Board Members:Gary W. Wood (Chairman), Wayne O. Carter (CEO), Barry S. Skikne (CMO), Wesley E. Griffitt
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with TVAX Biomedical, Inc.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.